治疗转移性癌症特应性皮炎的杜匹单抗

IF 2.2 4区医学 Q2 DERMATOLOGY

Australasian Journal of Dermatology Pub Date : 2024-05-03 DOI:10.1111/ajd.14296

Jessica McClatchy BBiomed MD, Gayle Ross MBBS (Hons) FACD

引用次数: 0

摘要

我们报告了一例 47 岁男性患者的病例，他患有严重的特应性皮炎和转移性肾细胞癌，使用杜比单抗后成功治愈。该病例进一步证实了杜比单抗在活动性恶性肿瘤患者中的安全性，目前这方面的数据还很有限。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Dupilumab for atopic dermatitis in metastatic cancer

We present a case of a 47-year-old male with severe atopic dermatitis and metastatic renal cell carcinoma managed successfully with dupilumab. This case further supports the safety of dupilumab in patients with active malignancy, an area currently with limited data.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Australasian Journal of Dermatology 医学-皮肤病学

CiteScore

3.20

自引率

5.00%

发文量

186

审稿时长

6-12 weeks

期刊介绍： Australasian Journal of Dermatology is the official journal of the Australasian College of Dermatologists and the New Zealand Dermatological Society, publishing peer-reviewed, original research articles, reviews and case reports dealing with all aspects of clinical practice and research in dermatology. Clinical presentations, medical and physical therapies and investigations, including dermatopathology and mycology, are covered. Short articles may be published under the headings ‘Signs, Syndromes and Diagnoses’, ‘Dermatopathology Presentation’, ‘Vignettes in Contact Dermatology’, ‘Surgery Corner’ or ‘Letters to the Editor’.